Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults

ClinicalTrials.gov ID: NCT05219968

Public ClinicalTrials.gov record NCT05219968. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 3:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ENLIGHTEN 1: A Phase III, Randomized, Blinded, Controlled, Parallel-Group Trial to Evaluate the Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis (CRS) in Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Multicenter, phase III, randomized, blinded, controlled, parallel group with safety extension phase with crossover or continued treatment.

Study identification

NCT ID
NCT05219968
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Lyra Therapeutics
Industry
Enrollment
196 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 26, 2022
Primary completion
Mar 3, 2024
Completion
Sep 15, 2024
Last update posted
May 1, 2025

2022 – 2024

United States locations

U.S. sites
26
U.S. states
13
U.S. cities
24
Facility City State ZIP Site status
Lyra Investigational Site Birmingham Alabama 35294-0012
Lyra Investigational Site Escondido California 92025
Lyra Investigational Site La Mesa California 91942
Lyra Investigational Site Sacramento California 95661
Lyra Investigational Site Torrance California 90503
Lyra Investigational Site Boca Raton Florida 33487-5713
Lyra Investigational Site Boynton Beach Florida 33426
Lyra Investigational Site Plantation Florida 33324
Lyra Investigational Site Port Saint Lucie Florida 34952
Lyra Investigational Site Chicago Illinois 60657
Lyra Investigational Site Louisville Kentucky 40220
Lyra Investigational Site Baltimore Maryland 21287
Lyra Investigational Site New Hyde Park New York 11042
Lyra Investigational Site New York New York 10003
Lyra Investigational Site New York New York 10016
Lyra Investigational Site New York New York 10029
Lyra Investigational Site Winston-Salem North Carolina 27103
Lyra Investigational Site Charleston South Carolina 29425
Lyra Investigational Site Spartanburg South Carolina 29303
Lyra Investigational Site Nashville Tennessee 37232-8605
Lyra Investigational Site Fort Worth Texas 76109
Lyra Investigational Site Houston Texas 77030
Lyra Investigational Site Mansfield Texas 76063
Lyra Investigational Site San Antonio Texas 78258
Lyra Investigational Site South Ogden Utah 84405
Lyra Investigational Site Norfolk Virginia 23507

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05219968, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 1, 2025 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05219968 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →